Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)
ID: RFA-DA-22-018 • Type: Posted
Overview
Category of Funding
Education
Health
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 7/29/21 the National Institutes of Health posted grant opportunity RFA-DA-22-018 for Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed).
The grant will be issued under grant program 93.279 Drug Abuse and Addiction Research Programs.
Timing
Posted Date
July 29, 2021, 12:00 a.m. EDT
Closing Date
Feb. 18, 2022, 12:00 a.m. EST Past Due
Last Updated
July 29, 2021, 2:59 p.m. EDT
Version
1
Archive Date
March 26, 2022
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 402-2541
Additional Information Site